Skip to main content
OpenTrials

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,109 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Active, Not Recruiting

Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

NCT05013099

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +40 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Providence Saint John's Cancer Institute Santa Monica, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma

NCT04309409

Conditions
Malignant Melanoma Stage II, Melanoma, Neoplasms, +10 more
Locations
  • Universitätsklinikum Würzburg - Klinik für Dermatologie, Venerologie und Allergologie Würzburg, Bavaria, Germany
  • Universitätsmedizin Rostock -Klinik und Poliklinik für Dermatologie und Venerologie Rostock, Mecklenburg-Vorpommern, Germany
  • Universitätsklinikum Augsburg, Campus Süd Augsburg, Germany
  • St. Josef-Hospital - Dermatologische Studienambulanz Bochum, Germany
View all 20 locations
View Trial Details
Active, Not Recruiting

Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma

NCT04949113

Conditions
Malignant Melanoma Stage III, Melanoma, Neoplasms, +10 more
Locations
  • The Angeles Clinic Los Angeles, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Melanoma Institute Australia (MIA) Sydney, New South Wales, Australia
  • Princess Alexandra Hospital Brisbane, Australia
View all 24 locations
View Trial Details
Active, Not Recruiting

Minimal SN Tumor Burden

NCT01942603

Conditions
Cutaneous Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • U.Z. Leuven - Campus Gasthuisberg Leuven, Belgium
  • CHRU de Lille Lille, France
  • CHU de Nice - Hopital De L'Archet Nice, France
  • Institut Gustave Roussy Paris, France
View all 22 locations
View Trial Details
Active, Not Recruiting

Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.

NCT05270044

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Centro Oncologico Korben CABA, Buenos Aires, Argentina
  • Centro de Investigaciones Medicas Mar del Plata Mar del Plata, Buenos Aires, Argentina
  • Fundacion CIDEA Ciudad Autonoma Bs As, Ciudad Autonoma Buenos Aires, Argentina
  • Sanatorio Britanico S.A. Rosario, Santa Fe Province, Argentina
View all 155 locations
View Trial Details

Related conditions